Diabetes — all decisions

The Board granted service connection for tinnitus, resolving reasonable doubt in favor of the Veteran. The other issues related to PTSD, sciatica nerve left leg, sleep apnea, and diabetes were remanded due to incomplete records.

The Board denied service connection for a left meniscus tear, right knee instability, chronic sinusitis or other condition of the nose, throat, larynx and pharynx, diabetes, type 1 or type 2, hypertension (high blood pressure), tinnitus, and visual impairment, including blurry vision, blindness and double vision.

The Board remands the claims for service connection for heart disease and diabetes mellitus to obtain additional medical opinions.

The Board granted service connection for type II diabetes mellitus and obstructive sleep apnea, but denied service connection for bilateral hearing loss and tinnitus.

The Board granted ratings of 30 to 40 percent for various diabetic neuropathies and restored a 10 percent rating for hypertension, while denying an increased rating for diabetes mellitus type II.

The Board granted service connection for diabetes mellitus, type II, a heart condition, and hypertension as secondary to the Veteran's service-connected acquired psychiatric disorder.

The appeal for entitlement to a total disability rating based on individual unemployability (TDIU) is dismissed as moot due to the Veteran's 100 percent combined rating assigned for his service-connected disabilities.

The Board denied service connection for diabetes mellitus, kidney disease, liver disease, and hypertension as the probative evidence did not establish a link between these conditions and the Veteran's period of active-duty service.

The Board granted service connection for diabetes mellitus type II, as secondary to the Veteran's service-connected hepatitis C with cirrhosis of the liver.

The Board remands the matter for a duty-to-assist error in failing to obtain a toxic exposure risk activity (TERA) opinion.

The Board denied the appellant's claim for an earlier effective date for the award of service connection for the cause of death, as well as the service connection claims for type II diabetes mellitus and chronic kidney disease.

The Board granted service connection for depressive disorder with anxiety disorder and bilateral lower extremity diabetic neuropathy, atherosclerotic cardiovascular disease, and chronic kidney disease, all secondary to diabetes mellitus. A 30 percent initial rating was granted for stasis dermatitis.

The Board remands the case to obtain new medical opinions regarding the Veteran's cause of death, specifically addressing his service in the Panama Canal Zone and potential exposure to toxins.

The Veteran's date of entitlement to TDIU most likely arose in 2009, but the earliest effective date granted is November 24, 2014.

The Board denied service connection for right knee, left knee, diabetes, left finger, and acquired psychiatric disorder due to the lack of new and relevant evidence. The claims for sleep apnea and headaches were remanded for further development.

The Board granted service connection for diabetes mellitus type II, hypertension as secondary to diabetes mellitus type II, and bilateral lower extremity diabetic peripheral neuropathy as secondary to diabetes mellitus type II.

The Board granted an effective date of March 8, 2024 for the grant of service connection for type 2 diabetes mellitus but denied earlier effective dates for atrial fibrillation and congestive heart failure. The other claims were remanded.

The appeal was dismissed due to the Veteran's death during its pendency.

The Veteran is granted a separate rating of 20 percent for benign prostatic hyperplasia (BPH) and denied an increased rating for diabetic nephropathy. The effective date for the service connection awards is August 26, 2023.

The Board denied service connection for all the claimed conditions as there was no evidence of a current disability or that any of the disabilities were related to active duty.